Embodied Conversational Agents for CervicalCancer Screening Abnormalities (ECA-CCSA)
Embodied Conversational Agents for Cervical Cancer Screening Abnormalities
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名：ECA-CCSA Research Coordinator
- 电话号码：617-651-9410
- 邮箱：saramyhealthnav@tuftsmedicine.org
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- age 21-65
- has an abnormal cervical cancer screening test result
- able to read in English or Spanish
Exclusion Criteria
- planning to move out of the study area during the follow up period
- pregnant
- incarcerated
- dose not have adequate vision or hearing to use the app
- diagnosed with cervical cancer
学习计划
研究是如何设计的？
设计细节
- 主要用途：诊断
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预：控制
仅护理标准
|
|
|
实验性的：Conversational agent only
Receives conversational agent to provide personalized education
|
People receiving the intervention will receive an animated health coach that works on a smartphone to guide them through the cervical cancer screening and care process to ensure they receive the follow up and treatment they need to prevent cancer.
|
|
实验性的：conversational agent and advocacy
Receives conversational agent to provide personalized education and also guidance on talking to family and friends about cancer screening
|
People receiving the intervention will receive an animated health coach that works on a smartphone to guide them through the cervical cancer screening and care process to ensure they receive the follow up and treatment they need to prevent cancer.
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
The proportion of participants who receive recommended follow-up testing and treatment.
大体时间：18 months
|
18 months
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
ACCESS, DISTRIBUTION, OR REUSE CONSIDERATIONS Data will be shared under a two-tier distribution system. All data that can be de-identified will be publicly shared. Data with specific confidentially risks, such as transcripts of interviews will not be shared publicly because of the difficulty masking the identity of participants. Data with increased risk of reidentification will be shared under a data-use agreement that clearly establish use rules to facilitate respondent confidentiality
WHETHER ACCESS TO SCIENTIFIC DATA WILL BE CONTROLLED
De-identified data will be freely available on the repository website. Restricted data (I.e., de-identified transcripts of interviews) will be available through a data use agreement. Data use agreements providing access to sensitive data will be managed by the repository of record.
PROTECTIONS FOR PRIVACY, RIGHTS, AND CONFIDENTIALITY OF HUMAN RESEARCH PARTICIPANTS
In order to ensure participant consent for data sharing, IRB paperwork and informed
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
- 分析代码
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.